{"id":11557,"date":"2026-05-27T16:04:00","date_gmt":"2026-05-27T14:04:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=cc25e5b2cf4b2e421c10c890a9d0ea0c"},"modified":"2026-05-27T16:04:00","modified_gmt":"2026-05-27T14:04:00","slug":"tidepool-launches-in-epic-showroom-to-bring-diabetes-device-data-into-the-point-of-care","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=11557","title":{"rendered":"Tidepool Launches in Epic Showroom to Bring Diabetes Device Data into the Point of Care"},"content":{"rendered":"<p class=\"bwalignc\">\n<i>Empowering clinicians with interactive, actionable diabetes data so they can focus on the patient, not the workflow<\/i><\/p><p>PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that <b>Tidepool+ Direct Connect<\/b> is now available through the Epic Showroom. Built on SMART on FHIR, Direct Connect brings interactive diabetes device data directly into Epic workflows, helping clinicians use patient data during routine care.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260527780274\/en\/773149\/5\/Tidepool_Logo_Light_Large_%281%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260527780274\/en\/773149\/22\/Tidepool_Logo_Light_Large_%281%29.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260527780274\/en\/773149\/5\/Tidepool_Logo_Light_Large_%281%29.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260527780274\/en\/773149\/21\/Tidepool_Logo_Light_Large_%281%29.jpg\" \/><\/a><p>\nEvery day, clinicians caring for people living with diabetes review device data, identify patterns, and translate that information into meaningful conversations during brief clinical visits. Cumbersome technology and data access processes distract from the clinician-patient relationship. Tidepool+ Direct Connect is designed to reduce the burden of bringing device data, along with relevant insights, into the clinical workflow where decisions are made.<\/p><p>\nWith Direct Connect, clinicians can launch Tidepool+ from inside Epic with a single click and evaluate the patient\u2019s data in interactive, dynamic Tidepool views without leaving the Epic environment. Insights can be reviewed in context and incorporated into clinical documentation, reducing potentially error-prone manual steps during visits.<\/p><p>\n\u201cTidepool has always focused on making diabetes data more accessible and actionable,\u201d said Brandon Arbiter, CEO. \u201cWe\u2019re excited to empower clinicians using Epic with insightful, intuitive patient data that fits directly into their encounter workflow so they can use it to improve care in the moment it matters.\u201d<\/p><p>\nTidepool+ Direct Connect supports scalable deployment across Epic-enabled health systems. This architecture enables faster, more intuitive rollouts, enhancing Tidepool\u2019s existing EHR integration capabilities.<\/p><p>\nDirect Connect is part of Tidepool\u2019s ongoing work to improve how clinicians can use timely and relevant diabetes device data during patient visits to help drive better health outcomes.<\/p><p>\nThe feature is now available in the Connection Hub of the <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fshowroom.epic.com%2FListing%3Fid%3D3700%26returnTitle%3D6&amp;esheet=54542220&amp;newsitemid=20260527780274&amp;lan=en-US&amp;anchor=Epic+Showroom&amp;index=1&amp;md5=bd87aa57e2f0b045d99770325cd01ba7\" rel=\"nofollow\" shape=\"rect\">Epic Showroom<\/a>.<\/p><p>\n<b>About Tidepool<\/b><\/p><p>\nTidepool is a recognized innovator in diabetes software on a mission to make diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers. Founded in 2013, Tidepool hosts a suite of software tools for people with diabetes and the clinics that serve them, including Tidepool+, Tidepool Mobile, Tidepool Uploader, and the FDA-cleared Tidepool Loop. Through strategic industry partnerships, Tidepool Loop is commercially available via partner-developed adaptations, such as the twiist\u2122 AID System powered by Tidepool, now available in the iOS App Store. Built with enterprise-grade security, the Tidepool platform is HIPAA-compliant and SOC 2 Type II-compliant. Tidepool is a registered 501(c)3 nonprofit organization. Learn more at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tidepool.org%2F&amp;esheet=54542220&amp;newsitemid=20260527780274&amp;lan=en-US&amp;anchor=tidepool.org&amp;index=2&amp;md5=cf9851317a8a81b35196e5c6fcddfa02\" rel=\"nofollow\" shape=\"rect\">tidepool.org<\/a>. Follow us on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftidepoolorg&amp;esheet=54542220&amp;newsitemid=20260527780274&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=aa5595d96ddca733efabcaa5b5c8c5fd\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media Contacts:<\/b><br\/>Saira Khan-Gallo\n<br\/><a  href=\"mailto:media@tidepool.org\" rel=\"nofollow\" shape=\"rect\">media@tidepool.org<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Empowering clinicians with interactive, actionable diabetes data so they can focus on the patient, not the workflowPALO ALTO, Calif.&#8211;(BUSINESS WIRE)&#8211;Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that Tidepool+&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11557","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11557"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11557\/revisions"}],"predecessor-version":[{"id":11558,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11557\/revisions\/11558"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}